Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Update on Offer for Subscription

22 Jun 2021 17:22

RNS Number : 7588C
Amati AIM VCT PLC
22 June 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

AMATI AIM VCT PLC

LEI: 213800HAEDBBK9RWCD25

22 June 2021

Update on Offer for Subscription

Following the announcement made on 12 April 2021, the Board of Amati AIM VCT PLC (the "Company") has discussed the size and structure of the proposed offer for subscription (the "Offer") with the Company's investment manager. Having considered the deployment of funds over the last six months and the current pipeline of investment opportunities, the Company is seeking to raise £30 million over a 12 month period from the date of publication of the prospectus related to the Offer. Initially, subscriptions will be accepted for the 2021/2022 tax year only.

The Directors will also have discretion to utilise an over-allotment facility of up to £30 million, either in whole or in part. This facility will only be utilised if sufficient Qualifying Investments have been made from the initial proceeds of the Offer and the investment manager has identified further investment opportunities. In this event, the Company may also accept applications in respect of the 2022/2023 tax year.

Subject to certain conditions, the Board intends to open the Offer to existing shareholders for a limited period prior to opening the Offer to new investors.

The prospectus, which will contain the full details and terms and conditions of the Offer, will be available from www.amatiglobal.com as soon as the Offer is launched, which is expected to be at the end of July 2021. A further announcement will be made when the prospectus is available.

Further information

For further information please contact Samantha Dalby on 0131 503 9115 or email: info@amatiglobal.com.

Notes

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe for or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAKKAAFXFEFA
Date   Source Headline
30th Nov 20209:52 amRNSNet Asset Value(s)
23rd Nov 20209:08 amRNSNet Asset Value(s)
19th Nov 20204:35 pmRNSTransaction in Own Shares
16th Nov 20202:03 pmRNSNet Asset Value(s)
9th Nov 20209:06 amRNSNet Asset Value(s)
2nd Nov 20204:47 pmRNSHolding(s) in Company
2nd Nov 20204:26 pmRNSNet Asset Value(s)
2nd Nov 20209:07 amRNSTotal Voting Rights
28th Oct 20203:07 pmRNSTransaction in Own Shares
27th Oct 20203:38 pmRNSIssue of Equity
23rd Oct 20204:18 pmRNSNet Asset Value(s)
20th Oct 20204:30 pmRNSIssue of Equity
16th Oct 20204:13 pmRNSNet Asset Value(s)
13th Oct 20202:11 pmRNSTransaction in Own Shares
13th Oct 202010:27 amRNSDirector/PDMR Shareholding
13th Oct 202010:02 amRNSIssue of Equity
12th Oct 20209:06 amRNSNet Asset Value(s)
5th Oct 20203:33 pmRNSDividend Declaration
5th Oct 20203:10 pmRNSHalf-year Report
2nd Oct 20203:52 pmRNSDirector/PDMR Shareholding
2nd Oct 20203:47 pmRNSIssue of Equity
1st Oct 20204:36 pmRNSNet Asset Value(s)
1st Oct 20202:28 pmRNSHolding(s) in Company
1st Oct 20209:34 amRNSTotal Voting Rights
25th Sep 20205:00 pmRNSNet Asset Value(s)
23rd Sep 20209:15 amRNSTransaction in Own Shares
21st Sep 20203:31 pmRNSIssue of Equity
21st Sep 20209:07 amRNSTransaction in Own Shares
21st Sep 20209:05 amRNSNet Asset Value(s)
15th Sep 20209:54 amRNSIssue of Equity
11th Sep 20204:28 pmRNSNet Asset Value(s)
8th Sep 20204:18 pmRNSTransaction in Own Shares
7th Sep 20203:01 pmRNSNet Asset Value(s)
2nd Sep 20204:56 pmRNSDirector/PDMR Shareholding
2nd Sep 20204:55 pmRNSIssue of Equity
2nd Sep 20209:36 amRNSNet Asset Value(s)
1st Sep 202012:27 pmRNSTotal Voting Rights
25th Aug 20201:58 pmRNSUpdate on offer for subscription
21st Aug 20204:50 pmRNSNet Asset Value(s)
18th Aug 20202:50 pmRNSTransaction in Own Shares
17th Aug 202011:12 amRNSNet Asset Value(s)
14th Aug 20203:08 pmRNSTransaction in Own Shares
14th Aug 20202:36 pmRNSUpdate on offer for subscription
10th Aug 202011:49 amRNSNet Asset Value(s)
5th Aug 20203:21 pmRNSTransaction in Own Shares
4th Aug 20209:53 amRNSTotal Voting Rights
4th Aug 20208:41 amRNSNet Asset Value(s)
30th Jul 20203:15 pmRNSTransaction in Own Shares
27th Jul 20209:53 amRNSDirector/PDMR Shareholding
27th Jul 20209:43 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.